PAN-622-toxin conjugate (Sensei Biotherapeutics)

N/A

Report date: 2025/03/19 11:40:00

Base Information

Drug NamePAN-622-toxin conjugate (Sensei Biotherapeutics)
Drug Alias NamePAN-622-DM1 conjugate (Panacea)PAN-622-DUO conjugate (Panacea)PAN-622-MMAE conjugate (Panacea)PAN-622-toxin conjugate (Panacea)antibody-toxin conjugate (Panacea) +[7] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate +[4] 
Mechanisms of ActionAspartyl (asparaginyl) β-hydroxylase inhibitors
TargetsAspartyl (asparaginyl) β-hydroxylase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSensei Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSensei Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A